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Trophic sentinel signaling
Metabolic stressuch as the human papillomavirus type 16 (HPV16) E7 oncoprotein, promotes
aberrant cell proliferation. In the absence of concurrent mitogenic stimuli, this triggers a cell-intrinsic
defense mechanism, the “trophic sentinel response”, which eliminates such aberrant cells. The molecular
pathways that elicit this response, however, remain obscure. We set up an experimental system to investigate
the trophic sentinel pathway triggered by HPV16 E7 expression in normal human keratinocytes, the natural
host cells of HPVs. Keratinocytes expressing HPV16 E7 cultured in E-medium undergo cell death and show
increased sub-G1 DNA content when grown to conﬂuence or under conditions of serum deprivation.
Moreover, HPV16 E7 expressing human keratinocytes express higher levels of the autophagy marker, LC3-II,
which can be abrogated by 3-methyladenine, an autophagy inhibitor. These ﬁndings indicate that even under
normal culture conditions, HPV16 E7 expression triggers metabolic stress that may result in autophagy, a
pathway implicated in carcinogenesis.
© 2008 Elsevier Inc. All rights reserved.IntroductionNormal cells undergo growth arrest when they reach conﬂuence
and/or are deprived of growth factors. Cells that have suffered a single
oncogenic hit, however, can encounter a situation of conﬂicting growth
signals when the oncogenic proliferative signal is inconsistent with
environmental antiproliferative cues. As a consequence, such cells
undergo an abortive process, the “trophic sentinel response”, which
can result in cell death, differentiation or senescence (reviewed in Evan
and Vousden, 2001). This phenomenonwas initially discovered in cells
expressing the adenovirus (Ad) E1A oncogene (Debbas and White,
1993; Putzer et al., 2000; Rao et al., 1992; Teodoro et al., 1995;White et
al., 1991), or c-myc (Evan et al., 1992). Co-expression of Ad E1B or Bcl-2
in Ad E1A or c-myc expressing cells, respectively, mutes this response
and results in cellular transformation (Debbas and White, 1993;
Pelengaris et al., 2002; White et al., 1991). Hence, the trophic sentinel
response is thought to represent a cellular tumor suppressive process
that eliminates aberrantly proliferating cells from an organism
(reviewed in Evan and Vousden, 2001).
High-risk human papillomaviruses (HPVs) are etiological agents of
cervical carcinoma and are also associated with other anogenital tract
malignancies as well as head and neck cancers (reviewed in Schiffmanital, The Channing Laboratories
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ünger).
l rights reserved.et al., 2007). Due to frequent viral genome integration during
malignant progression, high-risk HPV associated cancers consistently
express the two viral oncoproteins, E6 and E7. The best known cellular
targets of high-risk HPV E6 and E7 oncoproteins are the p53 and
retinoblastoma (pRB) tumor suppressor proteins, respectively
(reviewed in Munger et al., 2001).
Our group showed that IMR90 normal human diploid ﬁbroblasts
that express the high-risk HPV type 16 (HPV16) E7 oncoprotein are
predisposed to undergo cell death once the cells become conﬂuent
and/or are serum starved (Jones et al., 1997b). Induction of the trophic
sentinel response by HPV16 E7 correlated with its ability to destabilize
the retinoblastoma tumor suppressor pRB and to stabilize the p53
tumor suppressor. This effect was abrogated when the HPV16 E6
oncoprotein, which targets p53 for degradation (Scheffner et al., 1993;
Scheffner et al., 1990), or a dominant negative p53 mutant was co-
expressed (Eichten et al., 2004). Although caspase 3 is activated and
DNA fragmentation occurs in serum starved HPV16 E7 expressing
IMR90 cells, treatment with a pan-caspase inhibitor did not block cell
death in HPV16 E7 expressing IMR-90 cells. Hence, the trophic
sentinel response in HPV16 E7 expressing normal human ﬁbroblasts
depends on p53, but does not involve prototypical apoptosis (Eichten
et al., 2004) and requires additional mechanistic investigation.
To analyze the trophic sentinel response in a biologically relevant
cell type, normal human keratinocytes, we developed an assay system
where normal human keratinocytes are grown in E medium supplied
with 5% fetal bovine serum (FBS). We show that under these
Fig. 1. HPV16 E7 expressing normal human keratinocytes cultured in E medium are
prone to cell death upon serum deprivation. (A) Representative ﬂow cytometric cell
cycle analysis of control human foreskin keratinocytes (HFK) and HPV16 E7 expressing
populations (HFK 16E7) grown in E-mediumwith 5% FBS or in serum free E medium for
72 and 144 h. Similar results were obtained in three independent experiments. (B).
Representative ﬂow cytometric cell cycle analysis of telomerase immortalized normal
human oral keratinocytes (NOK) and a donor matched HPV16 E7 expressing line (NOK
E7) (Piboonniyom et al., 2003) grown in complete E-medium or in serum freemedium E
medium for 72 and 120 h. Similar results were obtained in three independent
experiments.
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serum deprivation or when the cells reach conﬂuence. In contrast,
HPV16 E7 expressing keratinocytes undergo cell death as evidenced
by an increase in the sub-G1 population. Furthermore, we detected
evidence of autophagy in HPV16 E7 expressing keratinocytes, even
when the cells were grown under normal tissue culture conditions.
These ﬁndings will allow a detailed mechanistic investigation of the
trophic sentinel response triggered by HPV16 E7 expression in
keratinocytes and suggest that E7 expression results in metabolic
stress even under normal tissue culture conditions.
Results
HPV16 E7 expressing primary human foreskin keratinocytes are prone to
cell death upon serum deprivation in E medium
Our previously published experiments on the HPV16 E7 induced
trophic sentinel pathway were performed with normal human
ﬁbroblasts rather than epithelial cells, the normal host cell type for
HPVs. In order to investigate the mechanistic details of the trophic
sentinel pathway in normal human keratinocytes, we ﬁrst needed to
develop a workable experimental system. Normal human keratino-
cytes aremost conveniently cultured in serum free growthmedia such
as Keratinocyte Serum FreeMedium (K-SFM) (Pirisi et al., 1987), which
is supplemented with pituitary extract and recombinant EGF. Upon
depletion of the pituitary extract from K-SFM, normal human
keratinocytes failed to undergo a cell cycle phase speciﬁc growth
arrest (J. Hasskarl and K. Münger, unpublished) whereas EGF depletion
inhibited cell migration but increased their proliferative capacity
(Hasskarl et al., 2006). Based on these results, we explored alternative
growth conditions for human keratinocytes. E medium, based on
Dulbecco's modiﬁed Eagle medium (DMEM) supplemented with F-12
nutrient mixture and a variety of other components such as insulin,
transferrin, adenine, triiodothyronine and hydrocortisone, as well as
fetal bovine serum (FBS) supports the growth of normal human
keratinocytes (Rheinwald, 1980; Rheinwald and Beckett, 1980). While
the original formulation also requires the presence of mitomycin C
treated Swiss 3T3 J2 murine ﬁbroblasts or their conditioned medium,
we did not include these components for our studies.
Primary human foreskin keratinocytes (HFKs) cultured in E
medium showed decreased cell growth in response to serum
deprivation as evidenced by lower cell density after 48 h of treatment
(data not shown). Cell cycle analysis by FACS revealed a modest
increase in the G1/S ratio, from 1.9 to 2.7, representing cell growth
arrest, but no apoptotic cells with sub-G1 DNA content were detected
at 72 or 144 h after serumwithdrawal (Fig. 1A, left panels). In order to
determine whether these culture conditions may be used to analyze
trophic sentinel signaling, we subjected a passage and donor matched
population of HPV16 E7 expressing HFKs to the same treatment. There
was nomarked decrease in cell density after 48 h of serum deprivation
in E-medium as compared to cells grown in E-medium supplemented
with 5% fetal bovine serum (FBS) (data not shown). FACS analysis
revealed an increase of cells in S and G2/M phases with a concomitant
decrease in G1 phase cells. Most importantly, there was a dramatic
increase of cells with sub-G1 DNA content from 0.2% at 72 h to 10% at
144 h after serum deprivation (Fig. 1A, right panels). Similar results
were obtained in three independent experiments. Hence, HPV16 E7
predisposes human foreskin keratinocytes to cell death in response to
growth factor withdrawal, similar to what we previously observed
with normal human diploid ﬁbroblasts (Jones et al., 1997b).
HPV16 E7 expressing hTERT immortalized human oral keratinocytes are
predisposed to cell death upon serum deprivation
Given that HFKs have a limited lifespan and their growth
characteristics change upon repeated passaging, they need to be re-derived regularly. Due to genetic differences between individual
donors, there can be signiﬁcant differences between cell populations.
To minimize these effects and to further conﬁrm that the trophic
sentinel pathway is functional in normal human keratinocytes, we
investigated a set of matched hTERT immortalized normal oral human
keratinocyte lines (NOK) with and without HPV16 E7 expression
(Piboonniyom et al., 2003). As with the primary HFKs, these cells were
adapted to grow to E-medium containing 5% FBS. After serum
withdrawal for 24 and 48 h, we observed increased cell shrinkage
and rounding in NOK E7 cells (data not shown). To quantify this
phenotype, we performed FACS analysis after serum withdrawal for
72 h and 120 h (Fig. 1B). In NOK cells we observed an ∼10% increase in
the G1 population, with concomitant decreases in the S and G2/M
populations. Therewas only a minor increase in the population of cells
with a sub-G1 DNA content from 0.9% to 2.7%. In NOK E7 cells,
however, we observed an increase in the sub-G1 population from 1.6%
to 8.5% at 120 h after serum deprivation (Fig. 1B). Similar results were
obtained in three independent experiments.
Increased incidence of cell death in HPV16 E7 expressing human
keratinocytes upon cell–cell contact
In the course of these experiments, we observed that the overall
incidence of cell death upon serum deprivation of NOK E7 cells was
dependent on the saturation density that the cells reached. We
consistently observed a higher number of ﬂoating cells in dense
cultures of NOK E7 cells than in NOK control cells, evenwhen the cells
were maintained in E medium supplied with 5% FBS. Hence, we
investigated whether E7 expression can trigger trophic sentinel
Fig. 2. NOK E7 cells are prone to cell death upon cell-to-cell contact. The percentage of
NOK and NOK E7 cells with sub-G1 DNA content as determined by ﬂow cytometry is
graphed for subconﬂuent and conﬂuent NOK and NOK E7 cells.
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and NOK E7 cells at low and high density and cultured them in E
medium with 5% FBS. Under high-density conditions, the cells
immediately reached conﬂuence and were maintained at conﬂuence
for three days before being harvested for FACS analysis (Fig. 2). NOK E7
cells exhibited a 2.9 fold increase of cells with a sub-G1 DNA content
after they reached conﬂuence (12.8% versus 4.4%), whereas the NOK
cells showed a 1.8 fold increase (1.1% versus 0.6%). The fact that NOK
E7 cells show a higher incidence of sub-G1 cells (4.4%) than NOK cells
(0.6%), even when seeded at low density, may be related to the fact
that NOK cells grow in dense clusters even in a sparsely seeded plate,
which appears sufﬁcient to cause cell death with NOK E7 cells. Similar
results were obtained in two independent experiments.
Hence, consistent with our earlier studies in human diploid
ﬁbroblasts, the trophic sentinel response in E7 expressing keratino-
cytes is also triggered by a growth inhibitory signal in response to cell-
to-cell contact.
HPV16 E7 expression in human keratinocytes induces an autophagy-like
process
Autophagy is a highly conserved cellular pathway that serves to
recycle damaged cellular structures (Mizushima et al., 2008). Under
conditions of nutrient limitation, this pathway is triggered as aFig. 3. Evidence for an autophagy-related process in NOK E7 cells. (A) Representative confoca
E7 (right panels) cells cultured in complete E-medium (top panels), serum free E-medium for
TO-PRO-3 (indicated by the pseudo blue coloration). (B). Quantiﬁcation of cells with punctate
different growth conditions. Bar graphs represent means and standard deviations of 4 (E-med
in each group. p-values as determined by unpaired t test are indicated. (C) Expression of au
cultured in complete Emedium before starvation. Serumwaswithdrawn for 4 h and 24 h.α-a
cell populations. (D) Expression level of LC3-II in NOK (N) and NOK E7 (N7) cells. Cells culture
MA (5mM) or the lysosomal protease inhibitors (Inhib) E64d (10 μg/ml) and pepstatin A (10 μ
as loading control to quantify the relative amount of LC3.survival mechanism to mobilize necessary nutrients. During this
process, autophagosomes are formed which subsequently fuse to
lysosomes to form autolysosomes where their contents are digested
and recycled. When autophagy is triggered over extended periods of
time in the absence of sufﬁcient exogenous energy sources, cells
eventually undergo death by self-digestion. A commonly used
molecular marker to assess autophagy is microtubule-associated
protein 1 light chain 3 (LC3). LC3 occurs in two forms in cells;
cytoplasmic LC3 I and lipidated LC3 II, which is associated with
autophagosomal membranes and forms cytoplasmic speckles
(“puncta”) (Mizushima, 2004).
Given the enhanced sensitivity of HPV16 E7 expressing cells to
growth factor withdrawal, we set out to determine whether HPV16 E7
expressing normal human keratinocytes show evidence for auto-
phagy-related processes. NOK and NOK E7 cells grown in complete E
medium or after 24 h of serumwithdrawal in E-mediumwere stained
with LC3 antibody. We detected stronger LC3 staining in NOK E7 cells
as compared to NOK control cells, both under normal tissue culture
conditions and after serum withdrawal. In addition, there was
increased incidence of cells with LC3 puncta in the NOK E7 cells as
compared to NOK cells, indicating increased incidence of autophago-
somes in NOK E7 cells (Fig. 3A). To test whether HPV16 E7 expression
activates an autophagy related process regardless of culture condi-
tions, we also stained NOK and NOK E7 cells grown in K-SFMwith LC3
antibody. Similar to what we observed when the cells were grown in
E-medium, the NOK-E7 population showed an increased number of
cells with LC3 puncta. A quantiﬁcation of these results corresponding
to an assessment of N600 cells in four (E medium) and three (K-SFM)
repeats is shown in Fig. 3B. NOK and NOK E7 cells grown in E medium
showed stronger LC3 staining than cells grown in K-SFM. This may be
due to one of the components of Emedium, hydrocortisone, which can
activate autophagy (Kalamidas and Kotoulas, 2000). Although the
percentage of cells with LC3 puncta is different under the various
conditions tested, there was a consistent 2 to 5 fold increase of cells
with LC3 puncta with NOK E7 cells as compared to NOK cells.
In these experiments, NOK and NOK E7 cells showed somewhat
fewer LC3 puncta after 24 h of serum deprivation. While these
differences were not statistically signiﬁcant, we reasoned that this
might due to fusion of autophagosomes with lysosomes. In order tol immunoﬂuorescence images of the LC3 staining patterns in NOK (left panels) and NOK
24 h (middle panels) or in K-SFM (bottom panels). Cell nuclei were counterstained with
LC3 staining (“LC3 puncta”) indicative of autophagy in NOK and NOK E7 cells under the
ium) or 3 (K-SFM) independent experimental repeats. More than 600 cells were counted
tophagosome associated LC3 II in NOK and NOK E7 cells. NOK and NOK E7 cells were
ctinwas used as loading control to quantify the relative amount of LC3-II in the different
d in keratinocyte serum free medium (K-SFM) were treated with autophagy inhibitor 3-
g/ml) for 4 h and subjected to immunoblot analysis using LC3 antibody.α-actinwas used
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response to serumwithdrawal, we analyzed expression of LC3 II at 4 h
after serum deprivation by Western blotting. LC3 II levels increased in
both NOK and NOK E7 cells, with NOK E7 cells exhibiting overall
stronger LC3 staining than NOKs (Fig. 3C). Consistent with the
immunoﬂuorescence experiments (Figs. 3A, B), the levels of LC3 II
decreased at 24 h after serum withdrawal (Fig. 3C).
In order to conﬁrm that the observed increase of LC3 puncta (Figs.
3A, B) and LC3 II expression (Fig. 3C) in NOK E7 cells is caused by
activation of autophagy, we treated NOK and NOK E7 cells with 3-
methyladenine (3-MA), a compound that inhibits autophagy at an
early stage (Seglen andGordon,1982). Consistentwith this notion, 3-MA
treatment decreased LC3 II expression in both NOK and NOK E7 cells
(Fig. 3D). Furthermore, when cells were treated with the lysosomal
protease inhibitors pepstatin A and E-64d, which inhibit LC3 II
degradation once autophagosomes have fused with lysosomes, we
detected increased amounts of LC3 II in NOK E7 cells (Fig. 3D). This
indicates that NOK E7 cells not only have more autophagosomes, but
also have an active autophagic ﬂux (Mizushima and Yoshimori, 2007).
Discussion
The productive phase of the HPV life cycle in an infected epithelium
is conﬁned to terminally differentiated layers. Squamous epithelial
cells normally undergo irreversible growth arrest upon differentiation.
Since HPV genome replication critically depends on the availability of
host replication enzymes, these viruses encode proteins that establish
and/or maintain a replication competent cellular milieu in differen-
tiated epithelial cells. HPV16 E7 has been shown to uncouple cellular
growth arrest fromdifferentiation and induces aberrant S-phase entry/
competence through a number of mechanisms including degradation
of the pRB tumor suppressor and inactivation of the cyclin dependent
kinase inhibitors p21CIP1 and p27KIP1 (Funk et al., 1997; Jones et al.,
1997a; Zerfass-Thome et al., 1996).
Such induction of aberrant cellular and/or viral DNA synthesis in
the absence of concurrent environmental mitogen stimulation,
however, can give rise to a situation of conﬂicting growth signals. In
otherwise normal cells, this triggers a cellular defensemechanism, the
“trophic sentinel response” that eliminates such deviant cells from the
proliferative pool through cell-type speciﬁc abortive processes such as
cell death, differentiation or senescence (reviewed in Evan and
Vousden, 2001). To avoid elimination, high-risk HPVs encode a second
oncoprotein, E6, which targets the p53 tumor suppressor protein for
ubiquitin-mediated, proteasomal proteolysis. Indeed, the HPV16 E7-
triggered trophic sentinel response in normal human diploid
ﬁbroblasts is abrogated by co-expression of HPV16 E6 or a dominant
negative p53 mutant (Eichten et al., 2004).
Our previous studies with HPV16 E7 expressing normal human
diploid ﬁbroblast have yielded interesting and somewhat unexpected
results. While E7 expression causes p53 stabilization similar as is
observed upon p53 activation through a DNA damage signal (Jones et
al., 1999), p53 remains transcriptionally inert even when the cells are
subjected to serum deprivation. In contrast to serum starved control
cells, we detected reduced phosphorylation of AKT in HPV-16 E7
expressing IMR90 ﬁbroblasts, indicating a potential role of this
survival kinase in HPV-16 E7 induced trophic sentinel signaling in
ﬁbroblasts. Moreover, we detected a marked induction of NF-kB
activity and transcriptional upregulation of two IGF-binding proteins,
IGFBP2 and IGFBP5, when serumwas withdrawn and addition of IGF-I
could partially rescue the serum deprivation induced cell death
response (Eichten et al., 2004). Another surprising aspect of these
studies was that a pan-caspase inhibitor, zVAD, did not inhibit the cell
death response despite of inhibition of DNA degradation. Hence the
mechanism of HPV16 E7 induced cell death in response to growth
factor deprivation is distinct from standard apoptosis and its
mechanism remains enigmatic.In order to warrant further mechanistic study, we ﬁrst needed to
establish a workable assay system of HPV16 induced trophic sentinel
signaling in the normal host cell type of these viruses, primary human
epithelial cells. Here we report that HPV16 E7 expression in two
human epithelial cell types, primary human foreskin keratinocytes
(HFKs) and hTERT immortalized normal oral keratinocytes (NOK)
reproducibly causes cell death when grown in E-medium and
subjected to serum deprivation. While normal cells stopped prolifer-
ating, we only detected minimal cell death under these conditions
(Fig. 1). Similar to what he had previously reported for HPV16 E7
expressing normal human diploid ﬁbroblasts, we also observed cell
death in HPV16 E7 expressing keratinocytes when they were
maintained at high cell density in complete, serum containing
medium (Fig. 2). Hence, these results suggest that similar to what
we observed in the ﬁbroblasts, HPV16 E7 expressing normal human
keratinocytes undergo cell death when they experience conﬂicting
growth signals.
While we have not yet performed detailed mechanistic studies on
trophic sentinel signaling triggered by HPV16 E7 expression in normal
human keratinocytes and do not know whether it is similar to what
we observed in ﬁbroblasts, we discovered evidence for activation of an
autophagy-related process in E7-expressing keratinocytes. Autophagy
is a type II form of cell death and represents an ancient, genetically
well-deﬁned signaling pathway that serves to maintain cell homeo-
stasis by recycling misfolded proteins as well as defective cellular
organelles. Under conditions of metabolic stress, such as growth factor
deprivation, autophagy is activated to provide cells with alternative
sources of energy for survival. Prolonged activation of autophagy,
however, can eventually lead to cell death by self-digestion (Mizush-
ima et al., 2008).
Given that HPV16 E7 expressing ﬁbroblast can undergo caspase
independent cell death, we decided to assess HPV16 E7 expressing
cells for autophagy using LC3 staining as a marker (Klionsky et al.,
2007; Tasdemir et al., 2008). In general, HPV16 E7 expressing
keratinocytes contained higher levels of diffuse cytoplasmic LC3
staining. This is consistent with a recent report that some autophagy
genes, including LC3, are transcriptionally regulated by E2F1 (Polager
et al., 2008), which is activated through pRB degradation in HPV16 E7
expressing keratinocytes. Indeed, we detected decreased LC3 expres-
sion in NIH 3T3 cells expressing the pRb/p107/130 defective HPV16 E7
ΔDLYCmutant as compared to wild type HPV16 E7 expressing NIH3T3
cells (data not shown). More importantly, we also observed an
increased number of cells where LC3 staining was conﬁned to discrete
cytoplasmic puncta, even when the cells were grown under nutrient-
rich conditions such as serum containing E-medium or standard K-
SFM (Fig. 3A). We also detected increased amounts of autophago-
some-associated LC3, LC3-II, in NOK E7 cells byWestern blot (Figs. 3C,
D). Moreover, when cells were treated with lysosomal protease
inhibitors, LC3-II levels further increased in NOK E7 cells, indicating
active autophagic ﬂux in NOK E7 cells. These ﬁndings suggest that
HPV16 E7 expression in keratinocytes activates an autophagy-like
process. One possibility is that aberrant cell proliferation induced by
E7 expression increases energy requirements. Moreover, E7 expres-
sion has been shown to cause a metabolic switch from normal aerobic
respiration to anaerobic metabolism (Zwerschke et al., 1999) that
generates considerably less ATP. Hence, HPV16 E7 expressing cells
may be experiencing metabolic stress even under normal growth
conditions, which may induce an autophagy-like process.
The ability of HPV16 E7 to induce an autophagy-related process is
interesting, given that the process of autophagy has been evaluated as
a target for anticancer therapy. Increased LC3 staining has been
observed in many tumor types including pancreatic (Fujii et al., 2008),
gastrointestinal (Yoshioka et al., 2008) and colon cancers (Sato et al.,
2007) and stronger LC3 staining correlated with particularly poor
prognosis in pancreatic cancer patients (Fujii et al., 2008). While
inhibiting autophagy decreased tumor cell survival both in vitro and in
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chemotherapy and radiotherapy in multiple carcinoma cell lines
(Apel et al., 2008), cells with defects in the autophagy pathway also
showed increased chromosome instability, signs of persistent DNA
damage and aneuploidy, whichmay promote carcinogenesis (Mathew
et al., 2007). Conversely, upregulation of autophagy has also been
shown to induce growth inhibition in glioma (Aoki et al., 2007) and
cholangiocellular carcinoma cells (Enomoto et al., 2007), and enhanced
response to radiotherapy of lung cancer in a mouse model (Kim et al.,
2008). Therefore, onemight envision strategies that inhibit or enhance
autophagy to be tested for clinical efﬁcacy (Carew et al., 2007;
Karantza-Wadsworth and White, 2007). It will be important to
determine whether there is increased autophagy in cervical cancers
andhow these tumors respond to inhibition or activation of autophagy.
In summary, we have established amodel system to investigate the
mechanistic details of the trophic sentinel response triggered by
HPV16 E7 expression in normal human keratinocytes. Moreover, we
provide evidence that HPV16 E7 expression in keratinocytes activates
an autophagy-related process, presumably as a result of metabolic
stress due to sustained proliferative activity and/or reprogramming of
the cellular metabolism to a less efﬁcient anaerobic mechanism
(Zwerschke et al., 1999). It will be important to determine whether
and how trophic sentinel signaling is connected to the induction of
this autophagy-related process.
Materials and methods
Cells and culture conditions
Primary human foreskin keratinocytes (HFKs) derived from
neonatal foreskins were isolated as described previously (Jones et
al., 1997a). HFK populations with stable expression of HPV16 E7 were
prepared by transfecting primary HFKs with p1435, a human β-actin
HPV16 E7 expression plasmid, or p1318, the parental vector (Munger
et al., 1989) as a control, using the Amaxa Human Keratinocyte
Nucleofector Kit (Amaxa Biosystems) according to the manufacturer's
instructions. Transfections included pcDNA3.1 (Invitrogen) (1:10 ratio)
to allow selection of transfected cells in 0.2 mg/ml G418. The hTERT
immortalized NOK and NOK E7 cells have been previously described
(Piboonniyom et al., 2003).
HFKs and NOKs were cultured either in Keratinocyte Serum Free
Medium (K-SFM, Invitrogen) supplemented with human recombinant
epidermal growth factor 1–53 (EGF 1–53), bovine pituitary extract
(BPE), penicillin (100 U/ml), streptomycin (100 μg/ml), gentamicin
(10 μg/ml), and amphotericin B (0.5 μg/ml) or in E medium
(Rheinwald, 1980; Rheinwald and Beckett, 1980). E-medium was
prepared by dissolving powdered Dulbecco's modiﬁed Eagle Medium
(DMEM; Invitrogen) and Ham's formulation of F-12 Nutrient Mixture
(Invitrogen) in distilled water. The solution was supplemented with
sodium bicarbonate (3.07 g/l), adenine (180 μM), insulin (5 μg/ml),
transferrin (5 μg/ml), triiodothyronine T3 (20 pM), hydrocortisone
(0.4 μg/ml), cholera enterotoxin (10 ng/ml), penicillin (100 U/ml),
streptomycin (100 μg/ml), nystatin (100 U/ml) and 5% Fetal Bovine
Serum (FBS).
For serum deprivation experiments, cells were seeded into six-well
plates at a density of 4 to 5×104 cells/well in complete E medium.
Unattached cells were removed by replacing themedium the day after
seeding. Cells were starved in serum-free E-medium or grown in
complete E-medium for the indicated times before analysis by FACS,
immunoﬂuorescence or Western blotting, as indicated.
For conﬂuence experiments, cells were seeded into six-well plates
at 6×105 cells/well in complete E-medium. Unattached cells were
removed by replacing the medium the day after seeding and the cells
were kept in complete E-medium for 72 h.
For some experiments NOK and NOK E7 cells were treatedwith the
autophagy inhibitor 3-methyladenine (#M9281, Sigma) at 5 mM orthe lysosomal protease inhibitors E-64d (#330005, Calbiochem) at
10 μg/ml and pepstatin A (#516481, Calbiochem) at 10 μg/ml for 4 h.
Fluorescence-activated cell sorting analysis (FACS)
Cells were washed with phosphate buffered saline (PBS) and ﬁxed
in 75% ethanol at room temperature for 10 min. After treatment with
RNAse A (20 μg/ml), DNA was stained with propidium iodide (50 μg/
ml). Samples were analyzed with a FACSCalibur system and CellQuest
software (Becton Dickinson).
Immunological methods
For immunoﬂuorescence experiments, cells were plated onto
coverslips and ﬁxedwith 3% paraformaldehyde in phosphate-buffered
saline (PBS) and permeabilized with 0.5% Triton X-100. Cells were
blocked with 10% goat serum in PBS at room temperature for 1 h and
incubated with a rabbit polyclonal LC3B antibody (#2775, Cell
Signaling) at a 1:200 dilution in PBS for 12 to 18 h at 4 °C followed
by an Alexa Fluor 488-conjugated goat anti rabbit antibody (1:1000 in
PBS; Invitrogen). Nuclei were counterstained with Hoechst 33258
(Sigma) and TO-PRO-3 (Invitrogen) dyes. Imageswere takenwith a laser
scanning Zeiss Axioskop PCM2000 confocal ﬂuorescence microscope.
For detection of LC3-II by Western blotting, cell lysates were
prepared in 0.5% Nonidet P-40 (NP40), 150 mM NaCl, 50 mM Tris–HCl
(pH7.5) and protease inhibitor cocktail (Roche). Extracts were cleared
by centrifugation at 4 °C at 16,000 g for 5 min and protein
concentrations were determined by the Bradford method (Bio-Rad).
200 μg aliquots were immediately analyzed by SDS-PAGE and
transferred to PVDF membranes (Immobilon-P; Millipore). The
membranes were blocked at room temperature for 1 h in 5% nonfat
dry milk in TNET buffer (200 mM Tris–HCl, 1 M NaCl, 50 mM EDTA,
0.1% Tween 20 [pH7.5]) and then probed with rabbit LC3B polyclonal
antibody (#2331, Novus biologicals; 1: 500) for 1 h at room
temperature. After three times of washing with TNET buffer,
secondary antibody was added to the membrane for 45 min at room
temperature. Immunodetection was performed using the enhanced
chemiluminescence system (PerkinElmer Life Sciences, Inc.), followed
by digital acquisition and quantiﬁcation on a Kodak 4000R Image
Station (Kodak) using Kodak Imaging Software (version 4.0). LC3-II
signals were normalized to α-actin (#MAB1501, Chemicon; 1:1000).
Acknowledgments
Supported by PHS grant R01 CA081135 (KM). We thank Dr. Amy
Baldwin for help in preparing HFKs and Dr. Margaret McLaughlin-
Drubin for helpful comments on the manuscript.
References
Aoki, H., Takada, Y., Kondo, S., Sawaya, R., Aggarwal, B.B., Kondo, Y., 2007. Evidence that
curcumin suppresses the growth of malignant gliomas in vitro and in vivo through
induction of autophagy: role of Akt and extracellular signal-regulated kinase
signaling pathways. Mol. Pharmacol. 72 (1), 29–39.
Apel, A., Herr, I., Schwarz, H., Rodemann, H.P., Mayer, A., 2008. Blocked autophagy
sensitizes resistant carcinoma cells to radiation therapy. Cancer Res. 68 (5),
1485–1494.
Carew, J.S., Nawrocki, S.T., Cleveland, J.L., 2007. Modulating autophagy for therapeutic
beneﬁt. Autophagy 3 (5), 464–467.
Debbas, M., White, E., 1993. Wild-type p53 mediates apoptosis by E1A, which is
inhibited by E1B. Genes Dev. 7 (4), 546–554.
Degenhardt, K., Mathew, R., Beaudoin, B., Bray, K., Anderson, D., Chen, G., Mukherjee, C.,
Shi, Y., Gelinas, C., Fan, Y., Nelson, D.A., Jin, S., White, E., 2006. Autophagy promotes
tumor cell survival and restricts necrosis, inﬂammation, and tumorigenesis. Cancer
Cell 10 (1), 51–64.
Eichten, A., Rud, D.S., Grace, M., Piboonniyom, S.O., Zacny, V., Munger, K., 2004.
Molecular pathways executing the “trophic sentinel” response in HPV-16 E7-
expressing normal human diploid ﬁbroblasts upon growth factor deprivation.
Virology 319 (1), 81–93.
Enomoto, M., Tsuchida, A., Miyazawa, K., Yokoyama, T., Kawakita, H., Tokita, H., Naito, M.,
Itoh, M., Ohyashiki, K., Aoki, T., 2007. Vitamin K2-induced cell growth inhibition via
197X. Zhou, K. Münger / Virology 385 (2009) 192–197autophagy formation in cholangiocellular carcinoma cell lines. Int. J. Mol. Med. 20
(6), 801–808.
Evan, G.I., Vousden, K.H., 2001. Proliferation, cell cycle and apoptosis in cancer. Nature
411 (6835), 342–348.
Evan, G.I., Wyllie, A.H., Gilbert, C.S., Littlewood, T.D., Land, H., Brooks, M., Waters, C.M.,
Penn, L.Z., Hancock, D.C., 1992. Induction of apoptosis in ﬁbroblasts by c-myc
protein. Cell 69 (1), 119–128.
Fujii, S., Mitsunaga, S., Yamazaki, M., Hasebe, T., Ishii, G., Kojima, M., Kinoshita, T., Ueno,
T., Esumi, H., Ochiai, A., 2008. Autophagy is activated in pancreatic cancer cells and
correlates with poor patient outcome. Cancer Sci. 99 (9), 1813–1819.
Funk, J.O., Waga, S., Harry, J.B., Espling, E., Stillman, B., Galloway, D.A., 1997. Inhibition of
CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction
with the HPV-16 E7 oncoprotein. Genes Dev. 11 (16), 2090–2100.
Hasskarl, J., Velupillai, P., Munger, K., 2006. Increased in vitro lifespan of primary human
keratinocytes correlates with decreased migration. J. Invest. Dermatol. 126 (5),
1179–1181.
Jones, D.L., Alani, R.M., Munger, K., 1997a. The human papillomavirus E7 oncoprotein
can uncouple cellular differentiation and proliferation in human keratinocytes by
abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev. 11 (16), 2101–2111.
Jones, D.L., Thompson, D.A., Munger, K., 1997b. Destabilization of the RB tumor
suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced
apoptosis. Virology 239 (1), 97–107.
Jones, D.L., Thompson, D.A., Suh-Burgmann, E., Grace, M., Munger, K., 1999. Expression
of the HPV E7 oncoprotein mimics but does not evoke a p53-dependent cellular
DNA damage response pathway. Virology 258 (2), 406–414.
Kalamidas, S.A., Kotoulas, O.B., 2000. Studies on the breakdown of glycogen in the
lysosomes: the effects of hydrocortisone. Histol. Histopathol. 15 (1), 29–35.
Karantza-Wadsworth, V., White, E., 2007. Role of autophagy in breast cancer. Autophagy
3 (6), 610–613.
Kim, K.W., Hwang, M., Moretti, L., Jaboin, J.J., Cha, Y.I., Lu, B., 2008. Autophagy
upregulation by inhibitors of caspase-3 and mTOR enhances radiotherapy in a
mouse model of lung cancer. Autophagy 4 (5), 659–668.
Klionsky, D.J., Cuervo, A.M., Seglen, P.O., 2007. Methods for monitoring autophagy from
yeast to human. Autophagy 3 (3), 181–206.
Mathew, R., Kongara, S., Beaudoin, B., Karp, C.M., Bray, K., Degenhardt, K., Chen, G., Jin, S.,
White, E., 2007. Autophagy suppresses tumor progression by limiting chromosomal
instability. Genes Dev. 21 (11), 1367–1381.
Mizushima, N., 2004. Methods for monitoring autophagy. Int. J. Biochem. Cell Biol. 36
(12), 2491–2502.
Mizushima, N., Yoshimori, T., 2007. How to interpret LC3 immunoblotting. Autophagy
3 (6), 542–545.
Mizushima, N., Levine, B., Cuervo, A.M., Klionsky, D.J., 2008. Autophagy ﬁghts disease
through cellular self-digestion. Nature 451 (7182), 1069–1075.
Munger, K., Phelps, W.C., Bubb, V., Howley, P.M., Schlegel, R., 1989. The E6 and E7 genes
of the human papillomavirus type 16 together are necessary and sufﬁcient for
transformation of primary human keratinocytes. J. Virol. 63 (10), 4417–4421.
Munger, K., Basile, J.R., Duensing, S., Eichten, A., Gonzalez, S.L., Grace, M., Zacny, V.L.,
2001. Biological activities and molecular targets of the human papillomavirus E7
oncoprotein. Oncogene 20 (54), 7888–7898.
Pelengaris, S., Khan, M., Evan, G.I., 2002. Suppression of Myc-induced apoptosis in beta
cells exposes multiple oncogenic properties of Myc and triggers carcinogenic
progression. Cell 109 (3), 321–334.Piboonniyom, S.O., Duensing, S., Swilling, N.W., Hasskarl, J., Hinds, P.W., Munger, K.,
2003. Abrogation of the retinoblastoma tumor suppressor checkpoint during
keratinocyte immortalization is not sufﬁcient for induction of centrosome-
mediated genomic instability. Cancer Res. 63 (2), 476–483.
Pirisi, L., Yasumoto, S., Feller, M., Doniger, J., DiPaolo, J.A., 1987. Transformation of human
ﬁbroblasts and keratinocytes with human papillomavirus type 16 DNA. J. Virol. 61
(4), 1061–1066.
Polager, S., Oﬁr, M., Ginsberg, D., 2008. E2F1 regulates autophagy and the transcription
of autophagy genes. Oncogene 27 (35), 4860–4864.
Putzer, B.M., Stiewe, T., Parssanedjad, K., Rega, S., Esche, H., 2000. E1A is sufﬁcient by
itself to induce apoptosis independent of p53 and other adenoviral gene products.
Cell Death Differ. 7 (2), 177–188.
Rao, L., Debbas, M., Sabbatini, P., Hockenbery, D., Korsmeyer, S., White, E., 1992. The
adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa
and Bcl-2 proteins. Proc. Natl. Acad. Sci. U. S. A. 89 (16), 7742–7746.
Rheinwald, J.G., 1980. Serial cultivation of normal human epidermal keratinocytes.
Methods Cell Biol. 21A, 229–254.
Rheinwald, J.G., Beckett, M.A., 1980. Defective terminal differentiation in culture as a
consistent and selectable character of malignant human keratinocytes. Cell 22 (2 Pt
2), 629–632.
Sato, K., Tsuchihara, K., Fujii, S., Sugiyama, M., Goya, T., Atomi, Y., Ueno, T., Ochiai, A.,
Esumi, H., 2007. Autophagy is activated in colorectal cancer cells and contributes to
the tolerance to nutrient deprivation. Cancer Res. 67 (20), 9677–9684.
Scheffner, M., Werness, B.A., Huibregtse, J.M., Levine, A.J., Howley, P.M., 1990. The E6
oncoprotein encoded by human papillomavirus types 16 and 18 promotes the
degradation of p53. Cell 63 (6), 1129–1136.
Scheffner, M., Huibregtse, J.M., Vierstra, R.D., Howley, P.M., 1993. The HPV-16 E6 and E6-
AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell
75 (3), 495–505.
Schiffman, M., Castle, P.E., Jeronimo, J., Rodriguez, A.C., Wacholder, S., 2007. Human
papillomavirus and cervical cancer. Lancet 370 (9590), 890–907.
Seglen, P.O., Gordon, P.B., 1982. 3-Methyladenine: speciﬁc inhibitor of autophagic/
lysosomal protein degradation in isolated rat hepatocytes. Proc. Natl. Acad. Sci. U. S. A.
79 (6), 1889–1892.
Tasdemir, E., Galluzzi, L., Maiuri, M.C., Criollo, A., Vitale, I., Hangen, E., Modjtahedi, N.,
Kroemer, G., 2008. Methods for assessing autophagy and autophagic cell death.
Methods Mol. Biol. 445, 29–76.
Teodoro, J.G., Shore, G.C., Branton, P.E., 1995. Adenovirus E1A proteins induce apoptosis
by both p53-dependent and p53-independent mechanisms. Oncogene 11 (3),
467–474.
White, E., Cipriani, R., Sabbatini, P., Denton, A., 1991. Adenovirus E1B 19-kilodalton
protein overcomes the cytotoxicity of E1A proteins. J. Virol. 65 (6), 2968–2978.
Yoshioka, A., Miyata, H., Doki, Y., Yamasaki, M., Sohma, I., Gotoh, K., Takiguchi, S.,
Fujiwara, Y., Uchiyama, Y., Monden, M., 2008. LC3, an autophagosome marker, is
highly expressed in gastrointestinal cancers. Int. J. Oncol. 33 (3), 461–468.
Zerfass-Thome, K., Zwerschke, W., Mannhardt, B., Tindle, R., Botz, J.W., Jansen-Durr, P.,
1996. Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type
16 E7 oncoprotein. Oncogene 13 (11), 2323–2330.
Zwerschke, W., Mazurek, S., Massimi, P., Banks, L., Eigenbrodt, E., Jansen-Durr, P.,
1999. Modulation of type M2 pyruvate kinase activity by the human
papillomavirus type 16 E7 oncoprotein. Proc. Natl. Acad. Sci. U. S. A. 96 (4),
1291–1296.
